Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre.

Bowen CD, Tallman GB, Hakki M, Lewis Ⅱ JS.

Mycoses. 2019 Aug;62(8):665-672. doi: 10.1111/myc.12924. Epub 2019 May 23.

PMID:
31050373
2.

Incidence and Outcomes of Bacterial Bloodstream Infections during Acute Graft-versus-Host Disease Involving the Gastrointestinal Tract after Hematopoietic Cell Transplantation.

Petersen J, Lindner C, Hakki M.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1648-1653. doi: 10.1016/j.bbmt.2019.04.016. Epub 2019 Apr 16.

PMID:
31002988
3.

Isavuconazole prophylaxis in patients with hematologic malignancies and hematopoietic-cell transplant recipients.

Fontana L, Perlin DS, Zhao Y, Noble BN, Lewis JS, Strasfeld L, Hakki M.

Clin Infect Dis. 2019 Apr 8. pii: ciz282. doi: 10.1093/cid/ciz282. [Epub ahead of print]

PMID:
30958538
4.
5.

Abdominal girth has a strong correlation with ultrasound-estimated epidural depth in parturients: a prospective observational study.

Canturk M, Karbancioglu Canturk F, Kocaoglu N, Hakki M.

J Anesth. 2019 Apr;33(2):273-278. doi: 10.1007/s00540-019-02621-9. Epub 2019 Feb 8.

PMID:
30734847
6.

[The effects of crystalloid warming on maternal body temperature and fetal outcomes: a randomized controlled trial].

Cantürk M, Cantürk FK, Kocaoğlu N, Hakki M.

Rev Bras Anestesiol. 2019 Jan - Feb;69(1):13-19. doi: 10.1016/j.bjan.2018.09.009. Epub 2018 Nov 15. Portuguese.

7.

Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.

Hakki M, Humphries RM, Hemarajata P, Tallman GB, Shields RK, Mettus RT, Doi Y, Lewis JS.

Clin Infect Dis. 2019 May 30;68(12):2045-2052. doi: 10.1093/cid/ciy825.

PMID:
30256922
8.
9.

Assessment of a cytomegalovirus serology dual-testing strategy in hematopoietic stem cell transplant recipients.

Perry DA, Hakki M.

Transpl Infect Dis. 2016 Oct;18(5):809-814. doi: 10.1111/tid.12591. Epub 2016 Sep 23.

PMID:
27502917
10.

Coccidioides immitis Cervical Lymphadenitis Complicated by Esophageal Fistula.

Loudin M, Clayburgh DR, Hakki M.

Case Rep Infect Dis. 2016;2016:8715405. doi: 10.1155/2016/8715405. Epub 2016 May 23.

11.

Humanized mouse models of human cytomegalovirus infection.

Crawford LB, Streblow DN, Hakki M, Nelson JA, Caposio P.

Curr Opin Virol. 2015 Aug;13:86-92. doi: 10.1016/j.coviro.2015.06.006. Epub 2015 Jun 25. Review.

12.

Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.

Iwahori S, Hakki M, Chou S, Kalejta RF.

J Biol Chem. 2015 Aug 7;290(32):19666-80. doi: 10.1074/jbc.M115.660043. Epub 2015 Jun 21.

13.

The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.

Hakki M, Rattray RM, Press RD.

J Clin Virol. 2015 Jul;68:1-5. doi: 10.1016/j.jcv.2015.04.012. Epub 2015 Apr 15.

PMID:
26071326
14.

Predictive value of testing nasopharyngeal samples for respiratory viruses in the setting of lower respiratory tract disease.

Hakki M, Strasfeld LM, Townes JM.

J Clin Microbiol. 2014 Nov;52(11):4020-2. doi: 10.1128/JCM.01944-14. Epub 2014 Aug 13.

15.

UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.

Gregg K, Hakki M, Kaul DR.

Transpl Infect Dis. 2014 Apr;16(2):320-3. doi: 10.1111/tid.12200. Epub 2014 Mar 13.

16.

Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.

Webel R, Hakki M, Prichard MN, Rawlinson WD, Marschall M, Chou S.

J Virol. 2014 May;88(9):4776-85. doi: 10.1128/JVI.00192-14. Epub 2014 Feb 12.

17.

HCMV infection of humanized mice after transplantation of G-CSF-mobilized peripheral blood stem cells from HCMV-seropositive donors.

Hakki M, Goldman DC, Streblow DN, Hamlin KL, Krekylwich CN, Fleming WH, Nelson JA.

Biol Blood Marrow Transplant. 2014 Jan;20(1):132-5. doi: 10.1016/j.bbmt.2013.10.019. Epub 2013 Oct 23.

18.

Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo.

Chou S, Hakki M, Villano S.

Antiviral Res. 2012 Aug;95(2):88-92. doi: 10.1016/j.antiviral.2012.05.013. Epub 2012 Jun 1.

19.

The biology of cytomegalovirus drug resistance.

Hakki M, Chou S.

Curr Opin Infect Dis. 2011 Dec;24(6):605-11. doi: 10.1097/QCO.0b013e32834cfb58. Review.

20.

Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.

Hakki M, Drummond C, Houser B, Marousek G, Chou S.

Antiviral Res. 2011 Nov;92(2):313-8. doi: 10.1016/j.antiviral.2011.08.019. Epub 2011 Sep 1.

21.

Cytomegalovirus in hematopoietic stem cell transplant recipients.

Ljungman P, Hakki M, Boeckh M.

Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69. doi: 10.1016/j.hoc.2010.11.011.

22.

Cytomegalovirus in hematopoietic stem cell transplant recipients.

Ljungman P, Hakki M, Boeckh M.

Infect Dis Clin North Am. 2010 Jun;24(2):319-37. doi: 10.1016/j.idc.2010.01.008. Review.

PMID:
20466273
23.

Comparison of three doses of epidural fentanyl followed by bupivacaine and fentanyl for labor analgesia.

Siddik-Sayyid SM, Taha SK, Azar MS, Hakki MA, Yaman RA, Baraka AS, Aouad MT.

Acta Anaesthesiol Scand. 2008 Oct;52(9):1285-90. doi: 10.1111/j.1399-6576.2008.01765.x.

PMID:
18823470
24.

Cellular serine/threonine phosphatase activity during human cytomegalovirus infection.

Hakki M, Geballe AP.

Virology. 2008 Oct 25;380(2):255-63. doi: 10.1016/j.virol.2008.07.028. Epub 2008 Aug 30.

25.

Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation.

Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M.

Bone Marrow Transplant. 2007 Jun;39(11):687-93. Epub 2007 Apr 2.

PMID:
17401395
26.

Does ondansetron or granisetron prevent subarachnoid morphine-induced pruritus after cesarean delivery?

Siddik-Sayyid SM, Aouad MT, Taha SK, Azar MS, Hakki MA, Kaddoum RN, Nasr VG, Yazbek VG, Baraka AS.

Anesth Analg. 2007 Feb;104(2):421-4.

PMID:
17242102
27.

Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1.

Hakki M, Marshall EE, De Niro KL, Geballe AP.

J Virol. 2006 Dec;80(23):11817-26. Epub 2006 Sep 20. Erratum in: J Virol. 2011 Dec;85(23):12837.

28.

Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.

Aouad MT, Siddik-Sayyid SM, Taha SK, Azar MS, Nasr VG, Hakki MA, Zoorob DG, Baraka AS.

Eur J Anaesthesiol. 2007 Feb;24(2):171-8. Epub 2006 Aug 29.

PMID:
16938159
29.
30.

Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.

Hakki M, Staab JF, Marr KA.

Antimicrob Agents Chemother. 2006 Jul;50(7):2522-4.

31.

Nasopharyngeal oxygen insufflation following pre-oxygenation using the four deep breath technique.

Taha SK, Siddik-Sayyid SM, El-Khatib MF, Dagher CM, Hakki MA, Baraka AS.

Anaesthesia. 2006 May;61(5):427-30.

32.

Double-stranded RNA binding by human cytomegalovirus pTRS1.

Hakki M, Geballe AP.

J Virol. 2005 Jun;79(12):7311-8. Erratum in: J Virol. 2011 Dec;85(23):12836.

33.

Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1.

Child SJ, Hakki M, De Niro KL, Geballe AP.

J Virol. 2004 Jan;78(1):197-205.

34.

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.

Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, White K, Corey L, Boeckh M.

Blood. 2003 Oct 15;102(8):3060-7. Epub 2003 Jul 3.

35.

An evaluation of setup uncertainties for patients treated to pelvic sites.

Hunt MA, Schultheiss TE, Desobry GE, Hakki M, Hanks GE.

Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):227-33.

PMID:
7721620

Supplemental Content

Support Center